SCHEMBL380951

SCHEMBL380951

CCCCC(C)CCCO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
SMN1; SMN2 Q16637 1/20 0.50
LMNA P02545 4/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ACE2 Q9BYF1 1/20 0.45
PRKD3 O94806 1/20 0.39
PRKCG P05129 1/20 0.39
PRKCB P05771 1/20 0.39
PRKCA P17252 1/20 0.39
PRKCH P24723 1/20 0.39
PRKCI P41743 1/20 0.39
PRKCE Q02156 1/20 0.39
PRKCQ Q04759 1/20 0.39
PRKCZ Q05513 1/20 0.39
PRKCD Q05655 1/20 0.39
PRKD1 Q15139 1/20 0.39
DNM1 Q05193 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropyl Alcohol SCHEMBL5562702 0.95 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Methylene Chloride SCHEMBL7441159 0.93 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL980762 0.92 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL16656699 0.92 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL978907 0.92 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL5354255 0.90 LMNA (0.57) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL15478674 0.90 LMNA (0.57) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL7797702 0.90 LMNA (0.57) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL10933749 0.90 LMNA (0.57) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL2223810 0.90 LMNA (0.57) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1038 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12618844-B2 Cancer IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2026-05-05 US claimed
EP-4674283-A1 A COMPOSITION FOR IMPARTING A CURED MEAT APPEARANCE AND/OR FLAVOUR Kerry Group Services International Limited (IE) 2026-01-07 EP claimed
US-20230068371-A1 CANCER IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-03-02 US claimed
CN-115280150-A Cancer treatment 帝国学院创新有限公司 2022-11-01 CN claimed
EP-3428612-B1 RAPID SAMPLE PREPARATION FOR ANALYTICAL ANALYSIS USING DISPERSIVE ENERGIZED EXTRACTION CEM CORP (US) 2021-10-06 EP claimed
US-10773276-B2 Method for forming multilayer coating film NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) 2020-09-15 US claimed
EP-3498855-B1 PROCESS FOR THE CULTIVATION OF MICROALGAE FOR THE PRODUCTION OF STARCH BIO-P SRL (IT) 2020-09-09 EP claimed
EP-3498855-A1 PROCESS FOR THE CULTIVATION OF MICROALGAE FOR THE PRODUCTION OF STARCH BIO-P S.r.l. (IT) 2019-06-19 EP claimed
US-10119092-B2 Use of polyesters as lubricants BASF SE (DE) 2018-11-06 US claimed
EP-2377844-B1 Cyclohexane polycarboxylic acid derivatives containing adjuvants BASF SE (DE) 2017-10-18 EP claimed
US-9688838-B1 Diisononyl terephthalate plasticizer and its use as well as process for producing the same NAN YA PLASTICS CORPORATION (TW) 2017-06-27 US claimed
EP-2377844-A2 Cyclohexane polycarboxylic acid derivatives containing adjuvants BASF SE (DE) 2011-10-19 EP claimed
US-7816553-B2 Cyclohexane polycarboxylic acid derivatives containing adjuvants BASF SE (DE) 2010-10-19 US claimed
US-12618844-B2 Cancer IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2026-05-05 US disclosed
EP-4674283-A1 A COMPOSITION FOR IMPARTING A CURED MEAT APPEARANCE AND/OR FLAVOUR Kerry Group Services International Limited (IE) 2026-01-07 EP disclosed
EP-4638409-A1 PLASTICIZER COMPOUND BASF SE (DE) 2025-10-29 EP disclosed
WO-1986003756-A1 MOLECULAR WEIGHT DISTRIBUTION MODIFICATION IN TUBULAR REACTOR EXXON RESEARCH AND ENGINEERING COMPANY (US) 1986-07-03 WO disclosed
EP-0094456-B1 PREPARATION OF ALCOHOLS FROM OLEFINS HAVING FROM 3 TO 7 CARBON ATOMS MONSANTO COMPANY (US) 1986-03-05 EP disclosed
US-4540753-A COORDINATION CATALYST EXXON RESEARCH & ENGINEERING CO. (US) 1985-09-10 US disclosed
EP-0129414-A2 Narrow MWD alpha-olefin copolymers EXXON RESEARCH AND ENGINEERING COMPANY (US) 1984-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12618844-B2 Cancer FABP2, CA12, CA13 ALDH1A1 236/4885SMN1; SMN2 1598/4885LMNA 1919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.